BUD31 Homolog (BUD31) Peptide
BUD31
WB
产品编号 ABIN925006
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for BUD31 Homolog (BUD31) Peptide (ABIN925006)
抗原
BUD31
(BUD31 Homolog (BUD31))
应用范围
Western Blotting (WB)
-
-
-
-
应用备注
- For use with EDG-2 (CT) polyclonal antibody ABIN187787. Incubate antibody neat with at least a 50 fold stoichiometric excess of blocking peptide at 37°C for 20 min. (molecular weights of peptide and antibody are ~2.5 kDa and ~160 kDa, respectively). Antibody can then be diluted to a concentration suitable for Western blot.
-
限制
- 仅限研究用
-
-
-
缓冲液
- 50 µg provided in PBS at 1 mg/ml.
-
储存条件
- -20 °C
-
-
- BUD31 (BUD31 Homolog (BUD31))
-
背景
- Blocking peptide for use in Western blotting with anti-EDG-2 (CT) (ABIN187787). Endothelial cell differentiation gene-2 (EDG-2) receptor is a high affinity receptor for lysophosphatidic acid (LPA). EDG-2, also known as lysopholipid receptor A1, Vzg-1, mrec1.3 or GPCR26, like all other EDG receptors, couple multiple (3 or more) types of G proteins and transduce decreases in c[AMP]i through Gi and increases in [Ca 2+ ]i by augmenting phos- pholipase C through Gq/11 and beta/gamma dimmers and by induction of PI3 kinase, p125 FAK, phospholipase D by activating rho through G12/13. Human EDG-2 is present in high levels on oligodendrocytes and certain human malignant T cell lines. EDG-2 receptors (with EDG-4) may play a role in protecting cardiomyocytes from apoptosis induced by hypoxia and andrenergic stimulation.
抗原
-
You are here:
